Implantable Cardiac Monitor Market Segmentation by Indication (Atrial Fibrillation, Cardiac Arrhythmias, Epilepsy & Others); By End Use Industry (Hospitals, Specialized Cardiac Centers, Ambulatory Surgical Centers & Others) – Global Demand Analysis & Opportunity Outlook 2027

Introduction to Implantable Cardiac Monitor

Implantable cardiac monitor is a small electrophysiology device about the size of USB memory stick that is used for long term monitoring of patient’s heart electrical activity in order to detect arrhythmias. The technology has eliminated the need for bulky external Holter monitor which requires wire leads attached to the patient. They can be inserted under the skin of the patient’s chest from where the heart activity is recorded. The device can be activated according to the range set by the doctors in order to identify and analyze an abnormal heart rhythm. It is used to monitor patients who are at high risk of atrial fibrillation and myocardial infraction.

A patient can be constantly monitored for 2 to 3 years with the help of these devices which are ideal for the patients who need continuous monitoring for an extended period.

Market Size and Forecast

Technological advancements in the cardiac monitor devices such as easier implant procedures is raising the demand for these devices on account of their ability to detect the cardiac arrhythmias and atrial fibrillation. Additionally, growing number of cardiac diseases and the rising need to monitor epilepsy disorder are some of the notable factors adding to the growth of the market.

The global implantable cardiac monitor market is anticipated to record a CAGR of around 7.9% over the forecast period i.e. 2019-2027. The market is segmented by indication & end use industry. The market is segmented by indication into atrial fibrillation, cardiac arrhythmias, epilepsy & others, out of which, the cardiac arrhythmias segment is anticipated to have leading shares on account of increase in the geriatric population and rise in the prevalence of the cardiac diseases worldwide. Additionally, atrial fibrillation segment is anticipated to grow at a significant rate over the forecast period. 

Get more information on this report: Download Sample PDF

The market is further segmented by end users into hospitals, specialized cardiac centers, and ambulatory surgical centers among others, out of which, the hospitals segment is anticipated to garner highest shares on account of implantation of the devices requiring hospitalization. Furthermore, the ambulatory surgical centers segment is expected to expand at a considerable rate on the back of supporting care, low cost treatment and ready availability of treatment at these centers as compared to hospitals. These centers are easily accessible and beneficial to patients.

The players in the market have invested in improving the treatment process for the patients by providing innovative ways of monitoring irregular heart rhythms on smartphones. This allows the doctors to directly keep the track of patient’s condition. Moreover, various companies holding a strong portfolio on the back of significant opportunities and innovative technologies pertaining to the product are now ready to enter the market.

Growth Drivers

Rise in Geriatric Population

According to statistics provided by W.H.O. (World Health Organization), the geriatric population, aged 60 years and older is anticipated to reach 2 Billion around the globe by the year 2050. Elderly people are more prone to diseases such as atrial fibrillation and cardiac arrhythmia, which occurs in old age and drives the need for monitoring the heart rate. The cardiovascular diseases such as heart stroke and improper functioning of the heart are becoming more prevalent, thereby increasing the demand for cardiac monitoring. External monitors are not realistic for old people to wear and carry on a daily basis. Implantable cardiac monitors offer better ECG monitoring and lasts for three years. The growing old age population is projected to create huge opportunities in the market during the forecast period.

Rise in Technological Advancements

The advancements in technology such as smartphone compatible cardiac monitors have been launched which provide ease of monitoring that are expected to considerably drive the growth of the market.

Restraints

Time Consuming and High cost

The implantation of cardiac monitors is a time consuming process. Additionally, the implantation requires hospitalization which is usually not preferred by people. They prefer taking medications instead of implantation of the monitor. Moreover, the treatment requires huge cost. These factors are expected to hamper the growth of the market during the forecast period.

Market Segmentation

Our-in depth analysis of the global implantable cardiac monitor market includes the following segments:

By Indication

• Atrial Fibrillation
• Cardiac Arrhythmias
• Epilepsy
• Others

By End Use Industry

• Hospitals
• Specialized Cardiac Centers
• Ambulatory Surgical Centers
• Others

By Region

On the basis of regional analysis, the global implantable cardiac monitor market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.

The market in North America region is anticipated to hold highest market share on account of high acceptance of these devices, high investments in health care and presence of major players in the region. According to a study conducted in the U.S., approximately 14 Million people are suffering from cardiac arrhythmia. This attracts investments in the research and development activities for observing the heart disease. Europe market is anticipated to have significant growth owing to rise in the prevalence of atrial fibrillation, increase in obesity along with rise in the geriatric population. Asia Pacific region is expected to hold a productive market with maximum growth potential on the back of improvement in the economic conditions and increase in the disposable income of the people.

The global implantable cardiac monitor market is further classified on the basis of region as follows:

• North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
• Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
• Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC,  Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
• Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Top Featured Companies Dominating the Market

• Medtronic
• Company Overview
• Business Strategy
• Key Product Offerings
• Financial Performance
• Key Performance Indicators
• Risk Analysis
• Recent Development
• Regional Presence
• SWOT Analysis
• Boston Scientific Corporation
• Abbott
• Biotronik Angel Medical Systems, Inc.
• Biosense Webster Inc.